All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will see whether they can be used as a third booster dose to protect against new variants.
A review of side effects reported with coronavirus vaccines by the EMA's safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty
Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world's biggest-selling medicines.